Congress Highlights

We are delighted to present to you the highlights of research in the scleroderma field presented at international congresses, in oral and poster presentation sessions.

43rd European Workshop for Rheumatology Research (EWRR) - Genoa (9-11 May 2024)

Maria Pellico Rosa (University of Milan) and Devis Benfaremo (Marche Polytechnic University, Ancona) from the EUSTAR Young Investigators Group (YIG) attended the 43rd EWRR Congress, on the 10th May 2024, and have reported on the highlights of latest research on Systemic Scleroderma presented at the event.

8th SSWC 2024 - Prague

EUSTAR, together with World Scleroderma Foundation, awarded 15 members of the EUSTAR Young Investigators Group (YIG) with grants to support their attendance at the 8^th Systemic Sclerosis World Congress (SSWC) in March 2024. As part of this, each awardee was assigned a congress topic to write a report about. These reports have been compiled into a congress highlights report.

Highlights from the EULAR 2018

Clinical Practice

A EUSTAR Young lnvestigator Group Report

Exciting clinical research was presented at the meeting, especially advances in the fields of imaging, risk prediction models and more personalised approaches to intervention for patients with SSc.

Basic Science

A EUSTAR Young lnvestigator Group Report

A large number of exciting abstracts
foccusing on basic science in the field of systemic sclerosis (SSc) were presented at the EULAR 2018 meeting. This article presents a summary of small selection of excellent work presented at the meeting.

Clinical Trials and Therapeutics

A EUSTAR Young lnvestigator Group Report

A large amount of new clinical research was presented at the EULAR 2018 annual meeting. Here we present a brief summary of some selected abstracts focusing on new potential therapeutic approaches for Systemic Sclerosis (SSc) and its complications.

Highlights from the ACR Congress 2017

Clinical Practice

A EUSTAR Young lnvestigator Group Report

A large amount of new clinical research was presented at the meeting that has the potential to deliver novel biomarkers, improved risk prediction models and more personalised approaches to intervention for patients with SSc over the coming years.

Basic Science

A EUSTAR Young lnvestigator Group Report

Sixty-two basic science abstracts were presented at the meeting. The following selection provides a synopsis of some of the recurring themes and notable findings reported at the meeting.

Clinical Trials and Therapeutics

A EUSTAR Young lnvestigator Group Report

The 2017 ACR meeting saw the reporting of a large number of interesting clinical trials that could result in new therapeutic options for patients with SSc over the coming years.